CFO sold ~$2.8M of CORT shares in the open market

Past results only. Not a forecast.

Record ID

0001193125-26-256011

Filed / recorded

Jun 4, 2026, 3:20 AM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CORCEPT THERAPEUTICS INC

Issuer CIK

1088856

Ticker

CORT

Reporting person

Atabak Mokari

Relationship

Officer

Officer title

Chief Financial Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Jun 1, 2026

Transaction code

S

Shares / units

40,000

Price per share

$70.00

Acquired / disposed

Disposed (D)

Shares owned after

15,257

Ownership form

Direct

Amendment

No

1. This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction.
2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.00 to $70.01 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
3. Includes 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.